Feasibility of a Pharmabuddy Care Service for patients with Parkinson’s disease
2024

Feasibility of a Pharmabuddy Care Service for Patients with Parkinson’s Disease

Sample size: 23 publication Evidence: moderate

Author Information

Author(s): Stuijt C. C. M., Karapinar-Çarkit F., van de Steeg – van Gompel C., van Laar T., van den Bemt B. J. F., Heringa M.

Primary Institution: Center of Excellence On Parkinson’s Disease, Groningen, the Netherlands

Hypothesis

The feasibility of a Pharmabuddy Care Service (PCS) for patients with Parkinson’s disease in primary care pharmacies is unknown.

Conclusion

This study shows PCS is highly appreciated by responding patients and can be feasible for primary care pharmacies.

Supporting Evidence

  • Patients rated their satisfaction with the service at a mean of 9.5 out of 10.
  • 89 interventions were made in response to 93 medication-related problems.
  • 20 out of 23 patients reported a positive effect from their interaction with a pharmabuddy.

Takeaway

The Pharmabuddy Care Service helps people with Parkinson's disease manage their medications better, and patients really like it.

Methodology

Patients and Pharmabuddies filled out questionnaires and participated in interviews to evaluate the feasibility of the service.

Potential Biases

Potential response bias due to the selection of patients who were more likely to have positive experiences.

Limitations

There was a selection bias among patients, and the collection of patient records was limited due to the COVID-19 pandemic.

Participant Demographics

67% of interviewed patients were female, and most handled their medication independently.

Digital Object Identifier (DOI)

10.1186/s12913-024-12057-x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication